213 Towers Watson. All rights reserved. 213 Casualty Loss Reserve Seminar Concurrent Session LOB-2: Current Issues In Managing Asbestos Liabilities Steven C. Lin, FCAS, MAAA September 16, 213 Agenda Asbestos claim statistics U.S. P&C insurers asbestos loss experience Key considerations in evaluating asbestos liabilities towerswatson.com 2 Asbestos claim statistics towerswatson.com 3
towerswatson.com 2,5 2, 1,5 1, 5 1, 9, 8, 7, 6, 5,, 3, 2, 1, 199 1991 1992 1993 199 1995 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 199 1991 1992 1993 199 1995 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211,5, 3,5 3, 2,5 2, 1,5 1, 5 1, 9, 8, 7, 6, 5,, 3, 2, 1, 199 1991 1992 1993 199 1995 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 199 1991 1992 1993 199 1995 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 Asbestos claim filings over the years Towers Watson Benchmark Claim Filings 1, 9, 8, 7, 6, 5,, 3, 2, 1, 1% 9% 8% 7% 6% 5% % 3% 2% 1% % 199 1991 1992 1993 199 1995 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 Filing TW Benchmark Malignant % Rate of new claim filings is down sharply from peak, but composition of claims has changed Currently 5% of new claims are for malignant diseases, compared to less than 1% in 2-23 Asbestos claim filing trends vary by disease Mesothelioma Lung and Other Misc. Cancers TW Benchmark TW Benchmark Nonmalignant Total TW Benchmark TW Benchmark towerswatson.com 5 Mesothelioma claims are the driver of future litigation costs Projected split of 212+ indemnity payments for large defendants Lung & Other Cancer 8% Nonmalignant 1% Mesothelioma 91% towerswatson.com 6
towerswatson.com 7 Mesothelioma incidence and claim counts 3,5 3, 2,5 2, 1,5 1, 5 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 TW Benchmark USCS Diag - Males USCS Diag - Females USCS Diag - Total Annual incidence (= diagnosis) counts show only slight changes over last decade Annual claim filing counts have fluctuated around 2, since 2 Variation due to non-epidemiological factors Projected future asbestos claim filings Estimated 212+ Filings Relative to 28-211 Level 1.2 12% 1. 1% 28-211 Avg = 1..8.6..2 8% 6% % 2%. 212 217 222 227 232 237 22 27 Filing % Mesothelioma Lung and Other Cancers Nonmalignant Malignant % Nearly 3, new mesothelioma claims in 212 & subsequent More than half of the new mesothelioma claims are expected in first 1 years towerswatson.com 8 U.S. P&C insurers asbestos loss experience towerswatson.com 9
towerswatson.com 1 Cumulative net incurred loss & expense $ Billions 9 8 7 6 5 3 2 1 9 8 7 6 5 3 2 1 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 212 Cumulative Paid ($52 billion) Case & IBNR Reserves ($23 billion) A.M. Best Ultimate ($85 billion) Cumulative incurred loss and expense reached $75 billion at year end 212 Source: Towers Watson analysis of financial statement data compiled by A.M. Best and other sources Grossed up for estimated amounts ceded by Fireman s Fund, Munich Re America and Swiss Re America to respective non-u.s. parents, but distortions remain (in particular, for Swiss Re and Berkshire) Annual net incurred and payments 9 8 7 6 $ Billions 5 3 2 1 1996 1997 1998 1999 2 21 22 23 2 25 26 27 28 29 21 211 212 Calendar Incurred Calendar Payments Annual incurred peaked at over $8 billion in 22, and has averaged $2.1 billion since 26 Annual payments appear to be slowly declining in last few years towerswatson.com 11 Patterns of reserve strengthening $ Billions 8 7 6 5 3 2 1 Top 12 A&E Insurers Change in Recognized Asbestos Net Ultimate Losses 23-212 Allianz Allstate AIG Berkshire Hathaway CNA Fairfax Financial Hartford Liberty Mutual Munich Re Nationwide Swiss Re Travelers All Other -1 23 2 25 26 27 28 29 21 211 212 Calendar Top 12 A&E insurers (measured by year end 212 A&E reserves) strengthened asbestos reserves by $23 billion during 23-212 Other insurers strengthened asbestos reserves by $8 billion towerswatson.com 12
towerswatson.com 13 Reasons for reserve strengthening in 211-12 Asbestos Reserve Strengthening During 211-12 ($M) Publicly Disclosed Reasons Higher legal costs All Other Tokio Marine US $87 Liberty Mutual High level of litigation involving individuals $75 Zurich alleging serious illness; as a result, increase in severity and moderately higher payments White Mountains Fairfax than previously anticipated; Also higher Allianz US $386 projected payments on assumed reinsurance accounts; However, Company s overall view of underlying asbestos environment AIG essentially unchanged Accretion of discount and Travelers "other changes" $3 Farmers Higher frequency and severity of ACE INA mesothelioma claims, particularly against Hartford certain smaller, more peripheral insureds $326 Munich Re US Industry reports suggested continued pressure Nationw ide Alleghany CNA $3 brought about by number of mesothelioma-related $2 deaths, new source of claimants and increase to non-products claims filings; However, reported claim activity for the company remained low Very limited public discussion Mixed signals as to whether reserve increases are in response to new changes in litigation environment or catch-up recognition of prior deficiencies Reserve development in last 5 years U.S. P&C Insurers Asbestos Reserve Development During 28-212 28-212 reserve development 35% Size of 28-212 3% Utica asbestos incurred 25% 2% 15% AIG 1% 5% Travelers % 1, 2, 3,, -5% Millions Net reserves at year end 27 Few insurers have released asbestos reserves, and only by small amounts None of the insurers with large asbestos reserves have released reserves towerswatson.com 1 Net survival ratios Top 12 A&E Insurers* Asbestos Net Survival Ratio as of 12/31/212 ($ in millions) Net Asbestos Paid 3- Net Reserves During Average Survival At 12/31/212 21-212 Annual Paid Ratio Allianz $1,162 $261 $87 13.3 Allstate 1,23 212 71 1.5 AIG 2,2 621 27 1.6 Berkshire Hathaway 2,22-292 -97-2.8 CNA 1,125 3 11 11.1 Fairfax Financial 871 23 81 1.7 Hartford 1,587 57 19 8.3 Liberty Mutual 895 66 215.2 Munich Re 1,32 18 8.8 Nationwide 1,386 1 138 1. Swiss Re 962 262 87 11. Travelers 2,366 869 29 8.2 All Other 6,98 2,56 89 7.2 P&C Industry 23, 7,1 2,367 9.7 Source: Towers Watson analysis of financial statement data compiled by A.M. Best and SNL Grossed up for amounts ceded by Fireman s Fund, Munich Re America, and Swiss Re America to respective non-u.s. parents *In terms of combined net A&E reserves at 12/31/212 Survival ratios are subject to distortion and must be interpreted with caution towerswatson.com 15
towerswatson.com 16 Future payments 3.5 U.S. P&C Insurance Industry Illustrative Future Asbestos Payments Annual Payments ($B) 3. 2.5 2. 1.5 1..5 3, 2,5 2, 1,5 1, 5 Mesothelioma Filing Count. 27 212 217 222 227 232 237 22 27 Future paid reserves Future reserves = paid = + $B Future paid = reserves + $8B Future paid = reserves + $12B Mesothelioma filings lagged 2 years In illustrative scenarios above, unpaid survival ratios range from 9.7 to 1.8 Meso filing pattern (lagged for 2 years for payment lag) implies survival ratio of 15.2 Insurer payments are accelerated relative to filings because of settlements, etc. Future incurred 3. U.S. P&C Insurance Industry Illustrative Future Asbestos Incurred 2.5 2. Annual Incurred ($B) 1.5 1..5. 27 212 217 222 227+ (.5) (1.) Future incurred = $12B Future incurred = $8B Future incurred = $B Future incurred = $B Illustrative scenarios above are equivalent to to 5.5 years of reserve strengthening at constant 212 rate (= survival ratio for incurred losses ) towerswatson.com 17 Key considerations in evaluating asbestos liabilities towerswatson.com 18
towerswatson.com 19 Key considerations in evaluating asbestos liabilities Disease incidence and claiming rates Asbestos bankruptcies and trusts Other legal issues Over 9 asbestos-related bankruptcies through 213 Number Of Asbestos Related Bankruptcies 1 13 12 1 Num ber 8 7 7 6 3 3 3 3 3 2 2 2 2 1 1 1 1 1 1 5 5 3 3 3 2 2 2 2 1 The rate of annual bankruptcy filings slowed after 22 towerswatson.com 2 Many bankruptcy trusts have begun paying claims; more money to come Source: Reprinted with permission by the RAND Corporation (www.rand.org); Figures S.1 and.2 from Asbestos Bankruptcy Trusts published 21 Established trusts paid at least $17.5 billion through 21 (GAO), with another $2 billion paid in 211 and $18 billion in remaining assets at year end 211 (Bates White) Significant additional sums will be available once Garlock, NARCO, Pittsburgh Corning, Quigley, WR Grace and other pending trusts become operational towerswatson.com 21
towerswatson.com 22 Battle over bankruptcy trusts and claimant information After major defendants go bankrupt, peripheral defendants pay more Theoretical mechanisms to ensure that defendants pay only their fair share Several liability, offsets, indirect claims, trust payment caps But mechanisms generally require information or action from others Defendants believe transparency of trust claimant information is key Exposure and compensation data Bankruptcy trusts resist demands for data Privacy, cost, fairness concerns Transparency unlikely to be attained in key jurisdictions in near term Bills introduced in LA, OH, OK, PA, TX, WI, WV, passed in OH Little movement in CA, IL, NY Federal legislative initiatives face uphill battle Judicial rules have had little or only limited success Other recent legal developments Components parts liability NY trial court judge upholds jury verdict against Crane (August 212) CA Supreme Court limits liabilities against equipment makers (January 212) Second hand exposure MD s highest court rules no duty to warn employee s family (July 213) Oakland, CA jury awards $27M to wife for second hand exposure (June 213) But appellate court in So. CA holds no duty of care to employee s family (May 212) Causation PA High Court rejects Any Fiber Theory (May 212) Nonproducts CA trial court effectively adopts Wallace & Gale (January 213) Case management and docket control Budget cuts in CA court system Changes in Madison County, IL, Philadelphia, PA and NJ IL Supreme Court rejects forum shopping (December 212) towerswatson.com 23 Asbestos: Industry outlook Some key legal issues still being litigated Claim litigation and coverage litigation Mesothelioma claims will remain the cost driver Gradual decline in new claims and high settlement values Settlement values in last few years have been volatile with no clear trend, though CWP % appears to have declined Increase in lung cancer claims since 211 Legal expenditures are higher than a few years ago Increase seems to have leveled off Insurance industry overall will continue to add to its reserves for several years Individual companies will diverge in their experience towerswatson.com 2
towerswatson.com Contact information Steven C. Lin, FCAS, MAAA Towers Watson 35 California St #2 San Francisco CA 91 +1 15 733 381 steve.lin@towerswatson.com 25